FENC CIK: 1211583

Fennec Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
26.7
FY23:
19.9
FY23:
26.9
FY24:
44.1
FY25:
67.0
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.21
FY23:
0.08
FY23:
0.01
FY24:
0.82
FY25:
3.51
Total assets
Change from FY22 to FY25
millions USD
FY22:
26.9
FY23:
20.0
FY23:
26.9
FY24:
44.9
FY25:
70.6

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
4.61
FY23:
–
FY23:
7.55
FY24:
6.92
FY25:
10.5
(negative)
Change from FY22 to FY25
millions USD
FY22:
24.9
FY23:
–
FY23:
30.9
FY24:
43.9
FY25:
24.6
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.57
FY23:
9.58
FY23:
−11.6
FY24:
−5.87
FY25:
35.5
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
26.9
FY23:
–
FY23:
26.9
FY24:
44.9
FY25:
70.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data